THC BioMed Intl Ltd. has entered into an agreement with the BC Liquor Distribution Branch (“BCLDB”) to supply a number of its products exclusively to British Columbia. The agreement was entered into after the BC Liquor Distribution Branch (BCLDB) met with THC BioMed management and toured THC’s flagship facility in Kelowna B.C.
The BCLDB will provide purchase orders to THC BioMed for the product quantities listed in the appendix to the agreement three months in advance of the available supply month.
- THC BioMed Ltd. has committed to:
- Supplying all produced dried flower product intended for the non-medical market, exclusively to the BCLDB until December 2019;
- Maintaining Wholesale Cost incl. Excise as listed in the appendix to the Agreement until December 2019; and
- Supplying the product as per the quantities and schedule listed in the appendix to the Agreement.
THC BioMed has agreed to exclusively supply the BCLDB with the following flower strains in 3.5-gram and 7-gram formats until December 2019:
THC Sativa LANDRACE
THC Indica LANDRACE
THC Hybrid LANDRACE
THC CBD Indica LANDRACE
West Coast Dream
THC BioMed will continue to supply all provinces with its best-selling pre-rolls as well as THC Kiss when the regulations permit.
“We are proud that our products will be featured in our home province of BC. We continue to strive to produce cannabis products that are pure, clean and potent. We also look forward to launching THC Kiss, a pure organically produced cannabis beverage, when regulations permit” commented John Miller, CEO and president of THC BioMed.
THC BioMed continues to work vigorously towards securing supply agreements with various provincial governments.